Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline vs Isotretinoin for TKI-Induced Acneiform Eruptions
NCT04864717Phase 4Unknown
- Sponsor
- Lady Davis Institute for Medical Research
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline, isotretinoin in acneiform eruption, sponsored by Lady Davis Institute for Medical Research. Status: unknown.
02
Drugs
doxycyclineisotretinoin
03
Conditions
acneiform eruption
Beyond the preview
Go deeper on NCT04864717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04864717.